PH27226A - Stable oxapenem-3-carboxylic acids - Google Patents
Stable oxapenem-3-carboxylic acidsInfo
- Publication number
- PH27226A PH27226A PH37299A PH37299A PH27226A PH 27226 A PH27226 A PH 27226A PH 37299 A PH37299 A PH 37299A PH 37299 A PH37299 A PH 37299A PH 27226 A PH27226 A PH 27226A
- Authority
- PH
- Philippines
- Prior art keywords
- carbon
- pharmaceutically acceptable
- bonded
- single bonds
- groups
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
- C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
- C07D205/09—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams with a sulfur atom directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19873725375 DE3725375A1 (de) | 1987-07-31 | 1987-07-31 | Stabile oxapenem-3-carbonsaeuren |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PH27226A true PH27226A (en) | 1993-05-04 |
Family
ID=6332772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PH37299A PH27226A (en) | 1987-07-31 | 1988-07-27 | Stable oxapenem-3-carboxylic acids |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5096899A (zh) |
| EP (1) | EP0301394B1 (zh) |
| JP (1) | JPH0819135B2 (zh) |
| KR (1) | KR890002169A (zh) |
| CN (1) | CN1031533A (zh) |
| AT (1) | ATE95521T1 (zh) |
| AU (1) | AU618013B2 (zh) |
| CA (1) | CA1339450C (zh) |
| DD (1) | DD282012A5 (zh) |
| DE (2) | DE3725375A1 (zh) |
| DK (1) | DK425888A (zh) |
| ES (1) | ES2060628T3 (zh) |
| FI (1) | FI883553A (zh) |
| HU (1) | HU203355B (zh) |
| IE (1) | IE63026B1 (zh) |
| IL (1) | IL87254A (zh) |
| NO (1) | NO883188L (zh) |
| PH (1) | PH27226A (zh) |
| PT (1) | PT88118B (zh) |
| ZA (1) | ZA885571B (zh) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3833693A1 (de) * | 1988-10-04 | 1990-04-05 | Bayer Ag | Stabile oxapenem-3-carbonsaeuren und ihre verwendung als ss-lactamasehemmer |
| DE4027928A1 (de) * | 1990-09-04 | 1992-03-05 | Bayer Ag | Neue 2-tert.substituierte methyl-oxapenem-3-carbonsaeuren und -ester, verfahren zu ihrer herstellung und ihre verwendung |
| DE4142423A1 (de) * | 1991-12-20 | 1993-06-24 | Pfaendler Hans Rudolf | ((ls)-hydroxyalkyl)oxapenem-3-carbonsaeuren und ihre verwendung als betalactamasehemmer |
| GB2369358A (en) * | 2000-10-19 | 2002-05-29 | Amura Ltd | Oxapenems and pharmaceutical compositions thereof |
| DE60135002D1 (de) * | 2000-10-19 | 2008-09-04 | Amura Ltd | Arzneizusammensetzungen enthaltend oxapenem-3-carbonsäuren |
| EP1199077A1 (en) * | 2000-10-19 | 2002-04-24 | Amura Limited | Stable compositions of oxapenem-3-carboxylic acids by Co-lyophilisation with pharmaceutical carriers |
| GB0106428D0 (en) * | 2001-03-15 | 2001-05-02 | Amura Ltd | Antibacterial composition |
| AR039774A1 (es) * | 2002-05-01 | 2005-03-02 | Wyeth Corp | 6-alquiliden-penems biciclicos como inhibidores de beta-lactamasas |
| AR039475A1 (es) * | 2002-05-01 | 2005-02-23 | Wyeth Corp | 6-alquiliden-penems triciclicos como inhibidores de beta-lactamasa |
| EP2167081B1 (en) | 2007-05-21 | 2013-06-26 | Hans Rudolf Pfaendler | Bactericidal anti-mrsa active pharmaceutical composition containing carbapenems |
| WO2009089380A2 (en) * | 2008-01-08 | 2009-07-16 | The Trustees Of Columbia University In The City Of New York | Methods for p2ry5 mediated regulation of hair growth and mutants thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1368236A (en) * | 1970-11-03 | 1974-09-25 | Glaxo Lab Ltd | Azetidinone derivatives and their preparation |
| AU498131B2 (en) * | 1974-02-26 | 1979-02-15 | Ciba-Geigy Ag | Production of cephems by cyclization |
| IE41109B1 (en) * | 1974-04-20 | 1979-10-24 | Beecham Group Ltd | Novel -lactam antibiotic from streptomyces clavuligerus |
| CA1136132A (en) * | 1975-02-17 | 1982-11-23 | Teruji Tsuji | Cyclization to form cephem ring and intermediates therefor |
| US4147864A (en) * | 1975-02-20 | 1979-04-03 | Ciba-Geigy Corporation | Process for the manufacture of 7β-amino-3-cephem-3-ol-4 carboxylic acid compounds |
| US4024152A (en) * | 1975-09-19 | 1977-05-17 | Eli Lilly And Company | 4-Dithio-3-imido-azetidin-2-ones |
| GB1529913A (en) * | 1976-02-04 | 1978-10-25 | Beecham Group Ltd | Beta-lactam compounds |
| US4228074A (en) * | 1976-09-09 | 1980-10-14 | Glaxo Laboratories Limited | Azetidinone derivatives |
| GB1591438A (en) * | 1976-09-09 | 1981-06-24 | Glaxo Lab Ltd | Clavem derivatives |
| GB1593275A (en) * | 1976-10-22 | 1981-07-15 | Glaxo Lab Ltd | Clavam derivatives |
| DK139377A (da) * | 1977-03-10 | 1978-09-11 | Beecham Group Ltd | Fremgangsmaade til fremstilling af ethere |
| US4260627A (en) * | 1978-10-24 | 1981-04-07 | Merck & Co., Inc. | 1-, 6- And 2-substituted-1-carba-2-penem-3-carboxylic acids |
| GB2045236A (en) * | 1979-03-26 | 1980-10-29 | Hoechst Uk Ltd | Oxapenem derivatives |
-
1987
- 1987-07-31 DE DE19873725375 patent/DE3725375A1/de not_active Withdrawn
-
1988
- 1988-07-18 NO NO88883188A patent/NO883188L/no unknown
- 1988-07-20 ES ES88111670T patent/ES2060628T3/es not_active Expired - Lifetime
- 1988-07-20 AT AT88111670T patent/ATE95521T1/de not_active IP Right Cessation
- 1988-07-20 EP EP88111670A patent/EP0301394B1/de not_active Expired - Lifetime
- 1988-07-20 DE DE88111670T patent/DE3884705D1/de not_active Expired - Lifetime
- 1988-07-26 AU AU20040/88A patent/AU618013B2/en not_active Expired
- 1988-07-27 PT PT88118A patent/PT88118B/pt not_active IP Right Cessation
- 1988-07-27 PH PH37299A patent/PH27226A/en unknown
- 1988-07-27 JP JP63185711A patent/JPH0819135B2/ja not_active Expired - Fee Related
- 1988-07-28 DD DD88318411A patent/DD282012A5/de not_active IP Right Cessation
- 1988-07-28 IL IL87254A patent/IL87254A/xx not_active IP Right Cessation
- 1988-07-28 FI FI883553A patent/FI883553A/fi not_active Application Discontinuation
- 1988-07-29 ZA ZA885571A patent/ZA885571B/xx unknown
- 1988-07-29 IE IE234788A patent/IE63026B1/en not_active IP Right Cessation
- 1988-07-29 CA CA000573432A patent/CA1339450C/en not_active Expired - Fee Related
- 1988-07-29 HU HU884042A patent/HU203355B/hu unknown
- 1988-07-29 DK DK425888A patent/DK425888A/da not_active Application Discontinuation
- 1988-07-30 KR KR1019880009849A patent/KR890002169A/ko not_active Application Discontinuation
- 1988-07-30 CN CN88104689A patent/CN1031533A/zh active Pending
-
1990
- 1990-08-24 US US07/574,573 patent/US5096899A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| ES2060628T3 (es) | 1994-12-01 |
| US5096899A (en) | 1992-03-17 |
| ZA885571B (en) | 1989-04-26 |
| DE3884705D1 (de) | 1993-11-11 |
| PT88118A (pt) | 1989-06-30 |
| CN1031533A (zh) | 1989-03-08 |
| DD282012A5 (de) | 1990-08-29 |
| DK425888A (da) | 1989-02-01 |
| PT88118B (pt) | 1995-03-01 |
| IE63026B1 (en) | 1995-03-22 |
| KR890002169A (ko) | 1989-04-08 |
| FI883553A0 (fi) | 1988-07-28 |
| AU2004088A (en) | 1989-02-02 |
| JPH0819135B2 (ja) | 1996-02-28 |
| DK425888D0 (da) | 1988-07-29 |
| HUT48889A (en) | 1989-07-28 |
| JPS6442484A (en) | 1989-02-14 |
| HU203355B (en) | 1991-07-29 |
| FI883553A (fi) | 1989-02-01 |
| EP0301394A1 (de) | 1989-02-01 |
| NO883188D0 (no) | 1988-07-18 |
| EP0301394B1 (de) | 1993-10-06 |
| AU618013B2 (en) | 1991-12-12 |
| IL87254A (en) | 1993-01-31 |
| CA1339450C (en) | 1997-09-09 |
| IE882347L (en) | 1989-01-31 |
| IL87254A0 (en) | 1988-12-30 |
| ATE95521T1 (de) | 1993-10-15 |
| NO883188L (no) | 1989-02-01 |
| DE3725375A1 (de) | 1989-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU643489B2 (en) | Antibacterial agents - II | |
| NO174806C (zh) | ||
| ZA918570B (en) | Azasteroid compounds for the treatment of prostatic hypertrophy,their preparation and use | |
| NO177428C (no) | Anvendelse av salter av metaller med carboxylsyrer for stabilisering av organopolysiloxanmasser | |
| PT98006A (pt) | Processo para a preparacao de novos derivados peptidicos | |
| MY131501A (en) | Process for the prepration of clavulanic acid | |
| AU8979191A (en) | 3,7-disubstituted indole derivatives | |
| ZA885571B (en) | Stable oxapenem-3-carboxylic acids | |
| FI904850A0 (fi) | Menetelmä uusien terapeuttisesti käyttökelpoisten 24-homo-D-vitamiinijohdannaisten valmistamiseksi | |
| FR2649110B1 (fr) | Nouveaux derives peptidiques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| ZA886930B (en) | Process for the synthesis of alpha n alkylated amino acids and esters thereof and to their application to the synthesis of carboxyalkyl dipeptides | |
| AU2235688A (en) | Process for the synthesis of alpha n alkylated amino acids and esters thereof. application to the synthesis of carboxyalkyl dipeptides. | |
| HUT45058A (en) | Process for producing 6-hydroxy-methyl-carbapenem derivatives and pharmaceuticals comprising the same as active ingredient | |
| PT83204A (en) | Process for preparing pharmaceutical compositions consisting of acylated phospholipios | |
| AU527523B2 (en) | Hexahydro-1,4-oxazepines | |
| ES2087421T3 (es) | Acidos (1's)-hidroxialquiloxapenem-3-carboxilicos y su uso como inhibidor de la betalactamasa. | |
| GB2282810A (en) | Process for the preparation of clavulanic acid | |
| HUT60495A (en) | Process for producing ergoline derivatives and pharmaceutical compositions comprising such compounds | |
| FR2608606B1 (fr) | Derives d'acide dibenzo(be)oxepinne-acetique, leur preparation et leur application en therapeutique |